Adapalene 0.3% / BPO 2.5% gel
RD.03.SPR.110232
Phase 3 small_molecule completed
Quick answer
Adapalene 0.3% / BPO 2.5% gel for Acne Vulgaris is a Phase 3 program (small_molecule) at Galderma Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Galderma Australia Pty Ltd
- Indication
- Acne Vulgaris
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed